HTR2A and psychotic disorder: Selective 5-HT2A antagonists/inverse agonists, such as Pimavanserin and M100907, can reverse psychosis-like behavior deficits in animal models of PD psychosis (PDP) without affecting motor behavior, suggesting that 5-HT2A antagonism/inverse agonism may aid in the treatment of PDP [127].